What is the recommended management for chronic venous insufficiency?

Management of Chronic Venous Insufficiency

Compression therapy (20-40 mm Hg) is the first-line treatment for chronic venous insufficiency, with endovenous ablation (radiofrequency or laser) reserved for patients with documented saphenous vein reflux who fail conservative management or have advanced disease (CEAP C4-C6). 1

Initial Diagnostic Approach

Start with duplex Doppler ultrasound of the lower extremity as the primary diagnostic modality 1. This should document:

• Presence and location of reflux (>500 ms retrograde flow)
• Deep venous system patency
• Great saphenous vein (GSV) and small saphenous vein status
• Perforator vein incompetence
• Alternative refluxing pathways

The CEAP classification system guides treatment intensity:

• C0-C1: Asymptomatic or telangiectasias
• C2-C3: Varicose veins with or without edema
• C4: Skin changes (pigmentation, eczema, lipodermatosclerosis)
• C5: Healed venous ulcer
• C6: Active venous ulcer

Treatment Algorithm by Disease Severity

For CEAP C2-C4 (Varicose Veins Without Ulceration)

Step 1: Compression Therapy

• Minimum pressure: 20-30 mm Hg for mild-moderate disease
• Higher pressure: 30-40 mm Hg for severe disease (C4-C6) 1
• Use inelastic compression over elastic bandaging for better outcomes
• Apply higher pressure at the calf rather than distal ankle (negative graduated compression) for improved ejection fraction 1

Critical caveat: Check ankle-brachial index (ABI) before compression:

• ABI 0.9-0.6: Safe to use 20-30 mm Hg compression
• ABI <0.6: Requires arterial revascularization first 1

Step 2: Endovenous Ablation (if compression fails or patient preference)

When saphenous reflux is documented on ultrasound, proceed with:

• Radiofrequency ablation (RFA) or endovenous laser ablation (EVLA) 1
• Both have equivalent efficacy and are superior to surgical stripping
• Lower complication rates than surgery (fewer bleeding, hematoma, wound infections, paresthesias) 1
• Improved early quality of life and faster recovery compared to surgical ligation 1

Step 3: Adjunctive Procedures

• Foam sclerotherapy for branch varicosities and smaller veins
• Microphlebectomy for bulging varicose veins not amenable to ablation
• These are complementary, not alternatives 1

For CEAP C5-C6 (Venous Leg Ulcers)

The evidence is strongest for compression therapy in ulcer healing and prevention of recurrence 1. Despite limited data correlating compression with quality of life in C2-C4 disease, there is clear evidence that compression therapy heals ulcers (C6) and prevents recurrence (C5) 1.

Treatment sequence:

1. Compression therapy (30-40 mm Hg inelastic) - First-line for wound healing 1

   • Velcro inelastic compression performs as well as 3-4 layer bandages
   • Continue indefinitely to prevent recurrence

2. Wound care - Standard protocols for ulcer management

3. Saphenous vein ablation - Perform once ulcer shows healing response 1

   • Addresses underlying reflux to prevent recurrence
   • Can be done as equivalent alternative to compression alone

4. Compression sclerotherapy - For tributary veins contributing to ulceration 1

For Post-Thrombotic Syndrome or Iliac Vein Obstruction

When duplex ultrasound shows:

• Peak systolic velocity ratio >2.5 across stenosis (indicates pressure gradient >3 mm Hg) 1
• Proximal obstruction with significant symptoms

Consider endovascular stenting of iliac veins 1. This is particularly useful for moderate-to-severe post-thrombotic syndrome with documented hemodynamically significant stenosis.

Key Clinical Pitfalls

Adherence is the primary cause of treatment failure 1. Address this with:

• Proper fitting demonstrations
• Written instructions
• Scheduled follow-up reminders
• Weekly monitoring initially 2

Don't miss arterial disease: 16% of patients with venous leg ulcers have concomitant arterial occlusive disease 1. Always check ABI before initiating compression.

Recurrence rates are high (15-35% at 2 years post-intervention) 1. This mandates:

• Lifelong compression therapy even after successful ablation
• Regular surveillance
• Early intervention for recurrent symptoms

Evidence Quality Note

While compression therapy is widely recommended, the guideline acknowledges that published data rely heavily on surrogate outcomes and subjective improvement rather than robust quality-of-life data for C2-C4 disease 1. However, the evidence is much stronger for C5-C6 disease (ulcer healing and prevention), making compression non-negotiable in advanced disease 1.

The 2023 ACR Appropriateness Criteria 1 and 2025 SCAI guidelines 3 provide the most current evidence-based framework, with endovenous ablation having largely replaced surgical stripping as the invasive standard due to superior outcomes and lower morbidity.